About the Authors
- Diana Karweina
-
Affiliation Breeding Biology and Molecular Genetics, Albrecht Daniel Thaer-Institute of Agri- and Horticulture, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
- Susanne Kreuzer-Redmer
-
Affiliation Breeding Biology and Molecular Genetics, Albrecht Daniel Thaer-Institute of Agri- and Horticulture, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
- Uwe Müller
-
Affiliation Breeding Biology and Molecular Genetics, Albrecht Daniel Thaer-Institute of Agri- and Horticulture, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
- Tobias Franken
-
Affiliation Breeding Biology and Molecular Genetics, Albrecht Daniel Thaer-Institute of Agri- and Horticulture, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
- Robert Pieper
-
Affiliation Institute of Animal Nutrition, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany
- Udo Baron
-
Affiliation Epiontis GmbH, Berlin, Germany
- Sven Olek
-
Affiliation Epiontis GmbH, Berlin, Germany
- Jürgen Zentek
-
Affiliation Institute of Animal Nutrition, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany
- Gudrun A. Brockmann
-
* E-mail: gudrun.brockmann@hu-berlin.de
Affiliation Breeding Biology and Molecular Genetics, Albrecht Daniel Thaer-Institute of Agri- and Horticulture, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
Competing Interests
Co-authors Udo Baron and Sven Olek are employed by Epiontis GmbH. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: SKR JZ GAB. Performed the experiments: DK TF. Analyzed the data: DK UM UB SO. Contributed reagents/materials/analysis tools: DK SKR UM RP UB SO. Wrote the paper: DK RP JZ GAB. Performed the animal trial: RP.